Antinociceptive Effects of Sustained-Release Buprenorphine in a Model of Incisional Pain in Rats (Rattus norvegicus)

Effective management of postoperative pain is an essential component of the care and welfare of laboratory animals. A sustained-release formulation of buprenorphine (Bup-SR) has recently been introduced to the veterinary market and has been reported to provide analgesia for as long as 72 h. Using ev...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Association for Laboratory Animal Science 2014-03, Vol.53 (2), p.193-197
Main Authors: Chum, Helen H, Jampachairsri, Katechan, McKeon, Gabriel P, Yeomans, David C, Pacharinsak, Cholawat, Felt, Stephen A
Format: Article
Language:English
Subjects:
Analgesics, Opioid - administration & dosage
Anesthesia
Animal Welfare
Animals
Buprenorphine - administration & dosage
Delayed-Action Preparations
Disease Models, Animal
Male
Pain Management - veterinary
Pain Measurement - drug effects
Pain Measurement - veterinary
Pain, Postoperative - drug therapy
Pain, Postoperative - prevention & control
Pain, Postoperative - veterinary
Random Allocation
Rats
Rats, Sprague-Dawley
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Effective management of postoperative pain is an essential component of the care and welfare of laboratory animals. A sustained-release formulation of buprenorphine (Bup-SR) has recently been introduced to the veterinary market and has been reported to provide analgesia for as long as 72 h. Using evoked mechanical and thermal hypersensitivity tests, we here evaluated the antinociceptive effects of Bup-SR in a model of incisional pain in rats. Paw withdrawal responses were obtained before and 1 through 4 d after surgery. Rats are assigned to receive Bup-SR (0.3, 1.2, or 4.5 mg/kg SC once) or buprenorphine HCl (Bup HCl, 0.05 mg/kg SC twice daily for 3 d). Responses to mechanical and thermal stimuli in the 1.2 and 4.5 Bup-SR groups did not differ from those of rats in the Bup HCl group. Thermal latency on day 3 in rats that received 0.3 mg/kg Bup-SR was significantly different from baseline, indicating that this dose effectively decreased thermal hypersensitivity for at least 48 h. Marked sedation occurred in rats in the 4.5 Bup-SR group. Our findings indicate that Bup-SR at 0.3 or 1.2 mg/kg SC is effective in minimizing hypersensitivity with minimal sedation for at least 48 h (thermal hypersensitivity) and 72 h, respectively, in the incisional pain model in rats.
ISSN:1559-6109